MediciNova, Inc.
MNOV
$1.32
$0.00760.58%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 5.43% | 6.77% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 16.84% | 0.59% | |||
| Operating Income | -12.63% | -0.59% | |||
| Income Before Tax | -14.56% | -1.96% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -14.56% | -1.76% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -14.56% | -1.76% | |||
| EBIT | -12.63% | -0.59% | |||
| EBITDA | -12.66% | -0.59% | |||
| EPS Basic | -14.55% | -1.74% | |||
| Normalized Basic EPS | -14.52% | -1.96% | |||
| EPS Diluted | -11.50% | -4.53% | |||
| Normalized Diluted EPS | -14.52% | -1.96% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||